TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Terumo ( (JP:4543) ) has provided an update.
Terumo Corporation reported a 5.2% increase in revenue and a significant rise in profits for the six months ending September 30, 2025, indicating strong operational performance. The company also announced an increase in dividends, reflecting confidence in continued financial growth and stability, which is likely to positively impact stakeholders and enhance its industry positioning.
The most recent analyst rating on (JP:4543) stock is a Buy with a Yen2729.00 price target. To see the full list of analyst forecasts on Terumo stock, see the JP:4543 Stock Forecast page.
More about Terumo
Terumo Corporation is a company listed on the Tokyo Stock Exchange, operating in the medical devices industry. It focuses on providing a range of healthcare products and services, with a strong emphasis on innovation and quality in medical technology.
Average Trading Volume: 4,015,024
Technical Sentiment Signal: Hold
Current Market Cap: Yen3725.6B
See more data about 4543 stock on TipRanks’ Stock Analysis page.